Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Florida was posted on June 30, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

A CHEMOTHERAPY-FREE TREATMENT REGIMEN FOR HER-2 POSITIVE BRE

Awarded
25C18State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Contract 25C18 is an award from the Florida Department of Health under the Florida Cancer Innovation Fund, granted to the H. Lee Moffitt Cancer Center and Research Institute, Inc. Led by Principal Investigator Hyo Han, the project focuses on developing a chemotherapy-free treatment regimen for HER-2 positive breast cancer by utilizing HER2-directed intratumoral dendritic cell immunotherapy in combination with Trastuzumab and Pertuzumab. The original contract amount is 1,429,728.00 dollars, with an initial start date of June 30, 2026. To ensure the successful completion of the research aims, the agreement has been modified through two amendments. Amendment A1 provided a no-cost extension of six months, extending the performance period to December 31, 2026. Subsequently, Amendment A2 updated the schedule of deliverables to align with this extended timeline. This initiative aligns with the broader goals of the Florida Cancer Innovation Fund to support emerging research trends and promising practices that serve as catalysts for cancer treatment innovation.

General Info

Florida Health awards Moffitt Cancer Center $1,429,728 for HER-2 breast cancer immunotherapy research.

Contract Value

$1,429,728

NAICS

N/A

Place of Performance

FL, USA

Set-Aside

NONE

Award Issued Date

Contract End Date

December 31, 2026

Documents

4
PDF, High priority: read this firstamendment
High
PDF, High priority: read this firstamendment
High
PDF, High priority: read this firstrfp
High
PDF, Low prioritycontract-document
Low

Read all 4 documents

Every page of every file, in your free workspace.

Read the documents

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyFlorida → Department Of Health
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
The Florida Cancer Innovation Fund provides grant support for innovative cancer-related research efforts, including emerging research trends and promising practices, which can serve as a catalyst for further exploration. TITLE: A Chemotherapy-free Treatment Regimen for HER-2 Positive Breast Cancer utilizing HER2-directed Intratumoral Dendritic Cell Immunotherapy plus Trastuzumab and Pertuzumab . PI: Hyo Han

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS